TY - JOUR
T1 - Overexpression of biologically active VEGF121 fusion proteins in Escherichia coli
AU - Kim, Sehoon
AU - Mohamedali, Khalid A.
AU - Cheung, Lawrence H.
AU - Rosenblum, Michael G.
N1 - Funding Information:
Research conducted, in part, by the Clayton Foundation for Research.
PY - 2007/2/20
Y1 - 2007/2/20
N2 - Vascular endothelial growth factor-A (VEGF) exists as five different isoforms, which exert their growth stimulatory effects through interaction with the FLK and KDR receptors. The VEGF121 isoform has been employed as a highly selective carrier of therapeutic agents to target tumor endothelial cells resulting in inhibition of tumor growth and metastasis. VEGF121 and VEGF121/rGel fusion toxin containing hexa-histidine tags were expressed in Escherichia coli AD494 (DE3) pLysS. Media containing glycerol as a primary carbon source increased the specific expression levels of soluble VEGF121 and VEGF121/rGel (mg/L/OD10) by more than two-fold over LB media when grown in a batchtype cultivation in a bioreactor. High cell densities over OD 40 were achieved using a fed-batch method and employing feeding medium containing glycerol and yeast extract. The overall production of the target proteins was improved 18-fold for VEGF121 (59.2 mg/L) and 27-fold for VEGF121/rGel (42.5 mg/L), respectively, compared to the conventional flask cultivation method (3.3 and 1.6 mg/L for VEGF121 and VEGF121/rGel, respectively). The purified VEGF121 and VEGF121/rGel fusion proteins were biologically active as assessed by phosphorylation of KDR receptors and cytotoxicity against KDR expressing cells.
AB - Vascular endothelial growth factor-A (VEGF) exists as five different isoforms, which exert their growth stimulatory effects through interaction with the FLK and KDR receptors. The VEGF121 isoform has been employed as a highly selective carrier of therapeutic agents to target tumor endothelial cells resulting in inhibition of tumor growth and metastasis. VEGF121 and VEGF121/rGel fusion toxin containing hexa-histidine tags were expressed in Escherichia coli AD494 (DE3) pLysS. Media containing glycerol as a primary carbon source increased the specific expression levels of soluble VEGF121 and VEGF121/rGel (mg/L/OD10) by more than two-fold over LB media when grown in a batchtype cultivation in a bioreactor. High cell densities over OD 40 were achieved using a fed-batch method and employing feeding medium containing glycerol and yeast extract. The overall production of the target proteins was improved 18-fold for VEGF121 (59.2 mg/L) and 27-fold for VEGF121/rGel (42.5 mg/L), respectively, compared to the conventional flask cultivation method (3.3 and 1.6 mg/L for VEGF121 and VEGF121/rGel, respectively). The purified VEGF121 and VEGF121/rGel fusion proteins were biologically active as assessed by phosphorylation of KDR receptors and cytotoxicity against KDR expressing cells.
KW - E. coli AD494 (DE3) pLysS
KW - Fed-batch cultivation
KW - VEGF/rGel
KW - Vascular endothelial growth factor (VEGF)
UR - http://www.scopus.com/inward/record.url?scp=33846358984&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846358984&partnerID=8YFLogxK
U2 - 10.1016/j.jbiotec.2006.11.027
DO - 10.1016/j.jbiotec.2006.11.027
M3 - Article
C2 - 17218033
AN - SCOPUS:33846358984
SN - 0168-1656
VL - 128
SP - 638
EP - 647
JO - Journal of Biotechnology
JF - Journal of Biotechnology
IS - 3
ER -